Lunsumio

Medicinal product

(Invented) name

Lunsumio

Active substance (s)

Mosunetuzumabas

Strength

1 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX25, mosunetuzumab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2022-06-03

Date of renewal

Documents

Lunsumio paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Mosunetuzumabas	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108840	94946	1094946	flakonas	1 ml N1		Receptinis	EU/1/22/1649/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-03	Registruotas